AEMD Stock Summary and Trading Ideas (Aethlon Medical | NASDAQ:AEMD)

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical trades on the NASDAQ stock market under the symbol AEMD.

As of January 9, 2026, AEMD stock price declined to $2.38 with 97,348 million shares trading.

AEMD has a beta of 1.11, meaning it tends to be more sensitive to market movements. AEMD has a correlation of 0.02 to the broad based SPY ETF.

AEMD has a market cap of $2.32 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AEMD traded as high as $696.00 and as low as $2.33.

The top ETF exchange traded funds that AEMD belongs to (by Net Assets): VXF.

AEMD has underperformed the market in the last year with a price return of -95.6% while the SPY ETF gained +19.0%. AEMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -67.7% and -7.0%, respectively, while the SPY returned +3.7% and +0.5%, respectively.

AEMD support price is $2.31 and resistance is $2.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEMD shares will trade within this expected range on the day.